Involvement of T44 molecules in an antigen-independent pathway of T cell activation. Analysis of the correlations to the T cell antigen- receptor complex

Prior studies indicate that the 9.3 monoclonal antibody (mAb) which defines a 44 kD T lineage-specific glycoprotein (T44) enhances the proliferative response of peripheral blood T lymphocytes to phytohemagglutinin (PHA) or allogeneic cells. The T44 molecule was expressed in both resting and activated T lymphocytes and in a subset of thymocytes, as assessed by indirect immunofluorescence and flow cytofluorometry. In view of the potential importance of T44 in T cell activation, we investigated the ability of the 9.3 (anti-T44) antibody to stimulate peripheral blood T lymphocytes under culture conditions giving optimal proliferative responses to anti-T3 mAb. Like UCHT1 (anti- T3) mAb, the 9.3 (anti-T44 mAb) promoted strong proliferative responses of purified T cells, provided that adherent cells were added to the culture. Maximal proliferation in response to 9.3 antibody was consistently detected at day 5 (at day 3 with anti-T3 or PHA). Moreover, triggering of T lymphocytes with 9.3 antibody (in the presence of adherent cells) resulted in strong IL-2 production that peaked at 48 h. Analysis of the physical and functional relationship between the T44 molecule and other molecules involved in T cell activation, including the clonotypically restricted Ti and the monomorphic T3 or T11 molecules, was carried out on a mutagenized jurkat T leukemia cell line. This mutant, termed JA3 (surface phenotype: T11+, T3+, 3A1+, T4-, T8-, DR-, Tac-, 4F2+, T44+) produced large amounts of IL-2 upon stimulation with PHA, anti-T3, or anticlonotypic mAb in conjunction with phorbol myristate acetate (or adherent cells). The molecules precipitated by anti-T44 mAb from 125I- labeled JA3 cells appeared as a diffuse band of Mr 40-45,000 under reducing conditions; under nonreducing conditions, a prominent band of Mr 80-85,000 was observed, while the Mr 40-45,000 band was greatly reduced. Thus, T44 molecules in both reducing and nonreducing conditions had relative molecular weights similar to that of molecules carrying clonotypic (Ti) determinants. In addition, like anti-Ti or anti-T3 mAb, anti-T44 antibody induced JA3 cells to produce large amounts of IL-2 in the presence of phorbol myristate acetate. Other similarities between T44 and molecules carrying clonotypic structures included the susceptibility to antibody-induced modulation and the late reexpression (72 h) at the cell surface after modulation. Taken together, these experiments suggest that anti-T44 mAb might recognize a monomorphic determinant of the T cell receptor molecule or be physically or functionally linked to the T3-Ti complex.(ABSTRACT TRUNCATED AT 400 WORDS)

[1]  M. López-Botet,et al.  Functional characterization of human thymocytes: a limiting dilution analysis of precursors with proliferative and cytolytic activities. , 1985, Journal of immunology.

[2]  A. Weiss,et al.  Requirement for the coexpression of T3 and the T cell antigen receptor on a malignant human T cell line , 1984, The Journal of experimental medicine.

[3]  E. Reinherz,et al.  Calcium dependency of antigen-specific (T3-Ti) and alternative (T11) pathways of human T-cell activation. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[4]  C. Y. Wang,et al.  T cell antiidiotypic antibodies reveal differences between two human leukemias , 1984, The Journal of experimental medicine.

[5]  W. Lesslauer,et al.  A 45-kDa human T-cell membrane glycoprotein functions in the regulation of cell proliferative responses. , 1984, European journal of biochemistry.

[6]  E. Reinherz,et al.  An alternative pathway of T-cell activation: A functional role for the 50 kd T11 sheep erythrocyte receptor protein , 1984, Cell.

[7]  G. Pantaleo,et al.  Clonal heterogeneity in the requirement for T3, T4, and T8 molecules in human cytolytic T lymphocyte function , 1984, The Journal of experimental medicine.

[8]  M. Bevan,et al.  Monoclonal antibodies specific for a murine cytotoxic T-lymphocyte clone. , 1984, Proceedings of the National Academy of Sciences of the United States of America.

[9]  R. Germain,et al.  Monoclonal antibodies against the antigen receptor on a cloned T-cell hybrid. , 1983, Proceedings of the National Academy of Sciences of the United States of America.

[10]  P. Marrack,et al.  The major histocompatibility complex-restricted antigen receptor on T cells in mouse and man: Identification of constant and variable peptides , 1983, Cell.

[11]  P. Marrack,et al.  The major histocompatibility complex-restricted antigen receptor on T cells. II. Role of the L3T4 product , 1983, The Journal of experimental medicine.

[12]  E. Reinherz,et al.  The human T cell receptor: Appearance in ontogeny and biochemical relationship of α and β subunits on IL-2 dependent clones and T cell tumors , 1983, Cell.

[13]  C. Janeway,et al.  Both a monoclonal antibody and antisera specific for determinants unique to individual cloned helper T cell lines can substitute for antigen and antigen-presenting cells in the activation of T cells , 1983, The Journal of experimental medicine.

[14]  C. Y. Wang,et al.  Idiotype-like molecules on cells of a human T cell leukemia , 1983, The Journal of experimental medicine.

[15]  E. Reinherz,et al.  Antigen-like effects of monoclonal antibodies directed at receptors on human T cell clones , 1983, The Journal of experimental medicine.

[16]  G. Pantaleo,et al.  Quantitative assessment of the pool size and subset distribution of cytolytic T lymphocytes within human resting or alloactivated peripheral blood T cell populations , 1983, The Journal of experimental medicine.

[17]  E. Reinherz,et al.  Evidence for the T3-associated 90K heterodimer as the T-cell antigen receptor , 1983, Nature.

[18]  M. Loken,et al.  A clone-specific monoclonal antibody that inhibits cytolysis of a cytolytic T cell clone , 1983, The Journal of experimental medicine.

[19]  E. Reinherz,et al.  Clonotypic structures involved in antigen-specific human T cell function. Relationship to the T3 molecular complex , 1983, The Journal of experimental medicine.

[20]  J. Allison,et al.  Tumor-specific antigen of murine T-lymphoma defined with monoclonal antibody. , 1982, Journal of immunology.

[21]  A. Boyd,et al.  Two monoclonal anti-human T lymphocyte antibodies have similar biologic effects and recognize the same cell surface antigen. , 1982, Journal of immunology.

[22]  E. Reinherz,et al.  Antigen recognition by human T lymphocytes is linked to surface expression of the T3 molecular complex , 1982, Cell.

[23]  U. Landegren,et al.  Selective inhibition of human T cell cytotoxicity at levels of target recognition or initiation of lysis by monoclonal OKT3 and Leu-2a antibodies , 1982, The Journal of experimental medicine.

[24]  L. Moretta,et al.  Human T cell subpopulations defined by a monoclonal antibody. II. Evidence for cell cooperation in the response to alloantigens and generation of cytolytic cells. , 1982, Journal of immunology.

[25]  B. Haynes Human T Lymphocyte Antigens as Defined by Monoclonal Antibodies , 1981, Immunological reviews.

[26]  L. Moretta,et al.  Surface markers of cloned human T cells with various cytolytic activities , 1981, The Journal of experimental medicine.

[27]  T. Chang,et al.  Does OKT3 monoclonal antibody react with an antigen-recognition structure on human T cells? , 1981, Proceedings of the National Academy of Sciences of the United States of America.

[28]  A. Hubbard,et al.  Externally disposed plasma membrane proteins. I. Enzymatic iodination of mouse L cells , 1975, The Journal of cell biology.

[29]  U. K. Laemmli,et al.  Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.

[30]  A. Moretta Frequency and surface phenotype of human T lymphocytes producing interleukin 2. Analysis by limiting dilution and cell cloning , 1985, European journal of immunology.

[31]  R. Goldin,et al.  A human T cell tumor which expresses the putative T cell antigen receptor , 1984, European journal of immunology.

[32]  C. Platsoucas Human T cell antigens involved in cytotoxicity against allogeneic or autologous chemically modified targets. Association of the Leu 2a/T8 antigen with effector‐target cell binding and of the T3/Leu 4 antigen with triggering , 1984, European journal of immunology.